BETNOVATE

This brand name is authorized in Albania, Austria, Australia, Brazil, Cyprus, Germany, Estonia, Spain, Hong Kong, Ireland, Israel, Lithuania, Malta, Mexico, New Zealand, Poland, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug BETNOVATE contains one active pharmaceutical ingredient (API):

1 Betamethasone 17-Valerate UNII 9IFA5XM7R2 - BETAMETHASONE VALERATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Betamethasone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
Betnovate Cream	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
BETNOVATE Lotion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07AC01	Betamethasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	Identifier(s): 97/52a
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10794D, 10799J, 10807T, 10808W, 10810Y, 2812B, 2813C, 4131K, 4132L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510601601164317, 510601602160315, 510601603175316, 510601604163311, 510601605161312, 510601608177317
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01508775, 03864304, 04174501
Country: EE	Ravimiamet	Identifier(s): 1004263, 1004870
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 40576, 45275
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 142094, 19228, 21765, 21767, 21799, 28186, 29133, 29134, 37467, 381200, 381201, 381203, 381204
Country: HK	Department of Health Drug Office	Identifier(s): 02807, 02811, 06910
Country: IE	Health Products Regulatory Authority	Identifier(s): 14893, 14907, 14966, 14974, 53910, 62138, 62146
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 254, 255
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1000337, 1000340, 1007722, 1088641, 1093401
Country: MT	Medicines Authority	Identifier(s): MA192/00201, MA192/00202, MA192/00203
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 61742, 62329, 68773
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 172
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100087311, 100087334
Country: SG	Health Sciences Authority	Identifier(s): 07714P, 08247P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522350414, 8699522356317, 8699522359295, 8699522380428, 8699522386321, 8699522389308, 8699522480432, 8699522490462
Country: ZA	Health Products Regulatory Authority	Identifier(s): G/13.4.1/1825, G/13.4.1/1829